Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 Active Not Recruiting Phase 1 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0113388 (Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04522336Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal CancerTreatment